Physician
Southern Coast Specialists, LLC
Southern Coast Specialists, LLC was paid $931K by Medicaid between Apr 2019 and Oct 2022, across 25 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 32% of everything it billed.
33Billing provider infoSOUTHERN COAST SPECIALISTS, LLC
LADSON, SC 29456
LADSON, SC 29456
33aNPI1386148617assigned 03/21/2018
33bProvider typePain Medicine (Anesthesiology) Physician
28Total paid$931K
24GClaims22,667
24DCodes billed25
24AFirst – last monthApr 2019 – Oct 2022
Compared with peers
Next to other Pain Medicine (Anesthesiology) Physician providers in South Carolina
Rank by total paid#3 of 25
Median peer was paid$41K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 15 | $501.35 | |
| 2020 | 8,438 | $344K | |
| 2021 | 8,856 | $366K | |
| 2022 | 5,358 | $221K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 7,022 | 6,550 | $295K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 25% | 3,462 | 3,339 | $237K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 18% | 3,944 | 3,756 | $163K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 2,261 | 2,140 | $143K |
| 62323 | 3.2% | 235 | 221 | $29K | |
| 99152 | 1.6% | 721 | 668 | $15K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.5% | 153 | 140 | $14K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 852 | 802 | $8K |
| 77002 | <1% | 125 | 119 | $6K | |
| 64483 | <1% | 36 | 36 | $4K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 710 | 652 | $3K |
| 64493 | <1% | 58 | 55 | $3K |
13 more codes
| 20610 | <1% | 87 | $3K | |
| 80305 | <1% | 151 | $2K | |
| 64494 | <1% | 58 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 17 | $1K |
| 64495 | <1% | 27 | $936.51 | |
| 99406 | <1% | 52 | $373.40 | |
| A4550 | Surgical trays | <1% | 57 | $301.30 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 1,074 | $280.06 |
| J3490 | Unclassified drugs | <1% | 160 | $252.35 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,315 | $190.57 |
| 96127 | <1% | 12 | $117.90 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 37 | $3.08 |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 0% | 41 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAGOSTINO, SABINO (MANAGING MEMBER)